These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

442 related items for PubMed ID: 9809923

  • 1. Increased expression of constitutive nitric oxide synthase III, but not inducible nitric oxide synthase II, in human heart failure.
    Stein B, Eschenhagen T, Rüdiger J, Scholz H, Förstermann U, Gath I.
    J Am Coll Cardiol; 1998 Nov; 32(5):1179-86. PubMed ID: 9809923
    [Abstract] [Full Text] [Related]

  • 2. Expression, activity and functional significance of inducible nitric oxide synthase in the failing human heart.
    Drexler H, Kästner S, Strobel A, Studer R, Brodde OE, Hasenfuss G.
    J Am Coll Cardiol; 1998 Oct; 32(4):955-63. PubMed ID: 9768717
    [Abstract] [Full Text] [Related]

  • 3. Nitric oxide synthase II mRNA expression in cardiac tissue of patients with heart failure undergoing cardiac transplantation.
    Orús J, Heras M, Morales-Ruiz M, Leivas A, Roig E, Rigol M, Rivera F, Sanz G, Jiménez W.
    J Heart Lung Transplant; 2000 Feb; 19(2):139-44. PubMed ID: 10703689
    [Abstract] [Full Text] [Related]

  • 4. Heterogeneous expression and activity of endothelial and inducible nitric oxide synthases in end-stage human heart failure: their relation to lesion site and beta-adrenergic receptor therapy.
    Fukuchi M, Hussain SN, Giaid A.
    Circulation; 1998 Jul 14; 98(2):132-9. PubMed ID: 9679719
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Expression of inducible nitric oxide synthase in human heart failure.
    Haywood GA, Tsao PS, von der Leyen HE, Mann MJ, Keeling PJ, Trindade PT, Lewis NP, Byrne CD, Rickenbacher PR, Bishopric NH, Cooke JP, McKenna WJ, Fowler MB.
    Circulation; 1996 Mar 15; 93(6):1087-94. PubMed ID: 8653828
    [Abstract] [Full Text] [Related]

  • 7. Endomyocardial nitric oxide synthase and left ventricular preload reserve in dilated cardiomyopathy.
    Heymes C, Vanderheyden M, Bronzwaer JG, Shah AM, Paulus WJ.
    Circulation; 1999 Jun 15; 99(23):3009-16. PubMed ID: 10368118
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Expression of inducible nitric oxide synthase is increased in patients with heart failure due to ischemic disease.
    Ferreiro CR, Chagas AC, Carvalho MH, Dantas AP, Scavone C, Souza LC, Buffolo E, da Luz PL.
    Braz J Med Biol Res; 2004 Sep 15; 37(9):1313-20. PubMed ID: 15334196
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Attenuation of myocardial ischemia/reperfusion injury by superinduction of inducible nitric oxide synthase.
    Kanno S, Lee PC, Zhang Y, Ho C, Griffith BP, Shears LL, Billiar TR.
    Circulation; 2000 Jun 13; 101(23):2742-8. PubMed ID: 10851213
    [Abstract] [Full Text] [Related]

  • 12. Inducible nitric oxide synthase (iNOS) in the human heart: expression and localization in congestive heart failure.
    Vejlstrup NG, Bouloumie A, Boesgaard S, Andersen CB, Nielsen-Kudsk JE, Mortensen SA, Kent JD, Harrison DG, Busse R, Aldershvile J.
    J Mol Cell Cardiol; 1998 Jun 13; 30(6):1215-23. PubMed ID: 9689595
    [Abstract] [Full Text] [Related]

  • 13. Ventricular assist device therapy normalizes inducible nitric oxide synthase expression and reduces cardiomyocyte apoptosis in the failing human heart.
    Patten RD, Denofrio D, El-Zaru M, Kakkar R, Saunders J, Celestin F, Warner K, Rastegar H, Khabbaz KR, Udelson JE, Konstam MA, Karas RH.
    J Am Coll Cardiol; 2005 May 03; 45(9):1419-24. PubMed ID: 15862412
    [Abstract] [Full Text] [Related]

  • 14. Sarcoplasmic reticulum Ca2+ATPase and phospholamban mRNA and protein levels in end-stage heart failure due to ischemic or dilated cardiomyopathy.
    Flesch M, Schwinger RH, Schnabel P, Schiffer F, van Gelder I, Bavendiek U, Südkamp M, Kuhn-Regnier F, Böhm M.
    J Mol Med (Berl); 1996 Jun 03; 74(6):321-32. PubMed ID: 8862513
    [Abstract] [Full Text] [Related]

  • 15. MK-954 (losartan potassium) exerts endothelial protective effects against reperfusion injury: evidence of an e-NOS mRNA overexpression after global ischemia.
    Barsotti A, Di Napoli P, Taccardi AA, Spina R, Stuppia L, Palka G, Barbacane RC, De Caterina R, Conti P.
    Atherosclerosis; 2001 Mar 03; 155(1):53-9. PubMed ID: 11223426
    [Abstract] [Full Text] [Related]

  • 16. Myocardial contractile function and heart rate in mice with myocyte-specific overexpression of endothelial nitric oxide synthase.
    Brunner F, Andrew P, Wölkart G, Zechner R, Mayer B.
    Circulation; 2001 Dec 18; 104(25):3097-102. PubMed ID: 11748107
    [Abstract] [Full Text] [Related]

  • 17. Angiotensin II type 2 receptor is upregulated in human heart with interstitial fibrosis, and cardiac fibroblasts are the major cell type for its expression.
    Tsutsumi Y, Matsubara H, Ohkubo N, Mori Y, Nozawa Y, Murasawa S, Kijima K, Maruyama K, Masaki H, Moriguchi Y, Shibasaki Y, Kamihata H, Inada M, Iwasaka T.
    Circ Res; 1998 Nov 16; 83(10):1035-46. PubMed ID: 9815151
    [Abstract] [Full Text] [Related]

  • 18. Role of platelet activating factor in cardiac dysfunction, apoptosis and nitric oxide synthase mRNA expression in the ischemic-reperfused rabbit heart.
    Loucks EB, Godin DV, Walley KR, McManus BM, Rahimian R, Granville DJ, Hong JM, Aktary FM, Qayumi AK.
    Can J Cardiol; 2003 Mar 15; 19(3):267-74. PubMed ID: 12677282
    [Abstract] [Full Text] [Related]

  • 19. Alterations of gene expression in failing myocardium following left ventricular assist device support.
    Chen Y, Park S, Li Y, Missov E, Hou M, Han X, Hall JL, Miller LW, Bache RJ.
    Physiol Genomics; 2003 Aug 15; 14(3):251-60. PubMed ID: 12824457
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.